Netsmart Technologies

ntst.com →

-53%

est. 2Y upside i

Healthcare

Rank

#3701

Sector

Healthcare IT

Est. Liquidity

~1Y

Data Quality

Data: Medium

Netsmart Technologies, a leader in niche healthcare IT with $585M revenue and $250M EBITDA, is currently valued at $5.0B.

Last updated: March 10, 2026

Bull (30%)+50%

Strong performance in niche markets and successful integration of acquisitions lead to competitive bidding in the sale process, pushing valuation to $7.5B (9.2x 2-year projected revenue of ~$810M) and delivering a +50% upside.

Base (25%)+10%

The sale concludes at a modest premium, reflecting steady 14% YoY growth to ~$760M revenue and a valuation of $5.5B (7.2x projected revenue), resulting in a +10% upside.

Bear (45%)-20%

The second sale attempt faces headwinds, with buyers concerned about the high 20x EBITDA multiple and integration of roll-up assets, leading to a valuation of $4.0B (5.6x projected revenue of ~$708M) and a -20% downside for common shareholders.

Est. time to liquidity~1.0 years

Preference Stack Risk

low

Funding Intensity

0%

With only $4M in total funding against a $5.0B valuation, liquidation preferences are negligible, meaning common stock holders are well-protected.

Dilution Risk

low

Given the imminent sale process and low historical funding, significant future dilution from additional funding rounds is unlikely.

Secondary Liquidity

limited

While the company is undergoing a sale process which could provide liquidity, there is no indication of an active employee secondary market outside of this event.

View all 7 open roles at Netsmart Technologies →

Last updated: February 18, 2026

Questions to Ask at the Interview

Strategic questions based on Netsmart Technologies's data — designed to show you've done your homework.

  • 1

    “Given the reported 20x EBITDA valuation and the prior sale attempt where buyers valued the company closer to $4B, how is Netsmart positioning itself to justify a premium valuation in the current sale process, particularly regarding the integration of its acquired assets?”

  • 2

    “Netsmart operates in niche markets where dominant incumbents like Oracle Health and Epic Systems could potentially expand. What specific strategies are in place to maintain and grow market share against such well-resourced competitors over the next 2-5 years?”

  • 3

    “With a sale process launched in early 2026, what is the expected timeline for a liquidity event, and how is the company preparing employees for potential changes in equity structure or ownership post-acquisition?”

Community

Valuation Sentiment

Our model estimates -53% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.